189 related articles for article (PubMed ID: 19925395)
1. An emerging strategy for cancer treatment targeting aberrant glycogen synthase kinase 3 beta.
Miyashita K; Nakada M; Shakoori A; Ishigaki Y; Shimasaki T; Motoo Y; Kawakami K; Minamoto T
Anticancer Agents Med Chem; 2009 Dec; 9(10):1114-22. PubMed ID: 19925395
[TBL] [Abstract][Full Text] [Related]
2. Potential therapeutic effect of glycogen synthase kinase 3beta inhibition against human glioblastoma.
Miyashita K; Kawakami K; Nakada M; Mai W; Shakoori A; Fujisawa H; Hayashi Y; Hamada J; Minamoto T
Clin Cancer Res; 2009 Feb; 15(3):887-97. PubMed ID: 19188159
[TBL] [Abstract][Full Text] [Related]
3. Glycogen synthase kinase 3β inhibition sensitizes human glioblastoma cells to temozolomide by affecting O6-methylguanine DNA methyltransferase promoter methylation via c-Myc signaling.
Pyko IV; Nakada M; Sabit H; Teng L; Furuyama N; Hayashi Y; Kawakami K; Minamoto T; Fedulau AS; Hamada J
Carcinogenesis; 2013 Oct; 34(10):2206-17. PubMed ID: 23715499
[TBL] [Abstract][Full Text] [Related]
4. Glycogen synthase kinase 3beta (GSK3beta) in tumorigenesis and cancer chemotherapy.
Luo J
Cancer Lett; 2009 Jan; 273(2):194-200. PubMed ID: 18606491
[TBL] [Abstract][Full Text] [Related]
5. Glycogen Synthase Kinase 3β in Cancer Biology and Treatment.
Domoto T; Uehara M; Bolidong D; Minamoto T
Cells; 2020 Jun; 9(6):. PubMed ID: 32503133
[TBL] [Abstract][Full Text] [Related]
6. Aberrant glycogen synthase kinase 3β is involved in pancreatic cancer cell invasion and resistance to therapy.
Kitano A; Shimasaki T; Chikano Y; Nakada M; Hirose M; Higashi T; Ishigaki Y; Endo Y; Takino T; Sato H; Sai Y; Miyamoto K; Motoo Y; Kawakami K; Minamoto T
PLoS One; 2013; 8(2):e55289. PubMed ID: 23408967
[TBL] [Abstract][Full Text] [Related]
7. Activation of p53-dependent apoptosis by acute ablation of glycogen synthase kinase-3beta in colorectal cancer cells.
Ghosh JC; Altieri DC
Clin Cancer Res; 2005 Jun; 11(12):4580-8. PubMed ID: 15958644
[TBL] [Abstract][Full Text] [Related]
8. Detection of active fraction of glycogen synthase kinase 3beta in cancer cells by nonradioisotopic in vitro kinase assay.
Mai W; Miyashita K; Shakoori A; Zhang B; Yu ZW; Takahashi Y; Motoo Y; Kawakami K; Minamoto T
Oncology; 2006; 71(3-4):297-305. PubMed ID: 17652946
[TBL] [Abstract][Full Text] [Related]
9. Glycogen-Synthase Kinase3beta/beta-catenin axis promotes angiogenesis through activation of vascular endothelial growth factor signaling in endothelial cells.
Skurk C; Maatz H; Rocnik E; Bialik A; Force T; Walsh K
Circ Res; 2005 Feb; 96(3):308-18. PubMed ID: 15662032
[TBL] [Abstract][Full Text] [Related]
10. Glycogen synthase kinase 3β sustains invasion of glioblastoma via the focal adhesion kinase, Rac1, and c-Jun N-terminal kinase-mediated pathway.
Chikano Y; Domoto T; Furuta T; Sabit H; Kitano-Tamura A; Pyko IV; Takino T; Sai Y; Hayashi Y; Sato H; Miyamoto K; Nakada M; Minamoto T
Mol Cancer Ther; 2015 Feb; 14(2):564-74. PubMed ID: 25504636
[TBL] [Abstract][Full Text] [Related]
11. Role of glycogen synthase kinase 3beta in rapamycin-mediated cell cycle regulation and chemosensitivity.
Dong J; Peng J; Zhang H; Mondesire WH; Jian W; Mills GB; Hung MC; Meric-Bernstam F
Cancer Res; 2005 Mar; 65(5):1961-72. PubMed ID: 15753396
[TBL] [Abstract][Full Text] [Related]
12. Deregulated GSK3{beta} sustains gastrointestinal cancer cells survival by modulating human telomerase reverse transcriptase and telomerase.
Mai W; Kawakami K; Shakoori A; Kyo S; Miyashita K; Yokoi K; Jin M; Shimasaki T; Motoo Y; Minamoto T
Clin Cancer Res; 2009 Nov; 15(22):6810-9. PubMed ID: 19903789
[TBL] [Abstract][Full Text] [Related]
13. Kinase-inactive glycogen synthase kinase 3beta promotes Wnt signaling and mammary tumorigenesis.
Farago M; Dominguez I; Landesman-Bollag E; Xu X; Rosner A; Cardiff RD; Seldin DC
Cancer Res; 2005 Jul; 65(13):5792-801. PubMed ID: 15994955
[TBL] [Abstract][Full Text] [Related]
14. Deregulated GSK3beta activity in colorectal cancer: its association with tumor cell survival and proliferation.
Shakoori A; Ougolkov A; Yu ZW; Zhang B; Modarressi MH; Billadeau DD; Mai M; Takahashi Y; Minamoto T
Biochem Biophys Res Commun; 2005 Sep; 334(4):1365-73. PubMed ID: 16043125
[TBL] [Abstract][Full Text] [Related]
15. AMPK inhibits MTDH expression via GSK3β and SIRT1 activation: potential role in triple negative breast cancer cell proliferation.
Gollavilli PN; Kanugula AK; Koyyada R; Karnewar S; Neeli PK; Kotamraju S
FEBS J; 2015 Oct; 282(20):3971-85. PubMed ID: 26236947
[TBL] [Abstract][Full Text] [Related]
16. Maintained activity of glycogen synthase kinase-3beta despite of its phosphorylation at serine-9 in okadaic acid-induced neurodegenerative model.
Lim YW; Yoon SY; Choi JE; Kim SM; Lee HS; Choe H; Lee SC; Kim DH
Biochem Biophys Res Commun; 2010 Apr; 395(2):207-12. PubMed ID: 20362550
[TBL] [Abstract][Full Text] [Related]
17. Endoplasmic reticulum stress-induced apoptosis is partly mediated by reduced insulin signaling through phosphatidylinositol 3-kinase/Akt and increased glycogen synthase kinase-3beta in mouse insulinoma cells.
Srinivasan S; Ohsugi M; Liu Z; Fatrai S; Bernal-Mizrachi E; Permutt MA
Diabetes; 2005 Apr; 54(4):968-75. PubMed ID: 15793234
[TBL] [Abstract][Full Text] [Related]
18. Regulation of glycogen synthase kinase-3beta by products of lipid peroxidation in human neuroblastoma cells.
Dozza B; Smith MA; Perry G; Tabaton M; Strocchi P
J Neurochem; 2004 Jun; 89(5):1224-32. PubMed ID: 15147515
[TBL] [Abstract][Full Text] [Related]
19. Glycogen synthase kinase-3 beta; a new target in pancreatic cancer?
Garcea G; Manson MM; Neal CP; Pattenden CJ; Sutton CD; Dennison AR; Berry DP
Curr Cancer Drug Targets; 2007 May; 7(3):209-15. PubMed ID: 17504118
[TBL] [Abstract][Full Text] [Related]
20. Cross-talk between glycogen synthase kinase 3β (GSK3β) and p38MAPK regulates myocyte enhancer factor 2 (MEF2) activity in skeletal and cardiac muscle.
Dionyssiou MG; Nowacki NB; Hashemi S; Zhao J; Kerr A; Tsushima RG; McDermott JC
J Mol Cell Cardiol; 2013 Jan; 54():35-44. PubMed ID: 23137781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
